US mesothelioma patterns 1973-2002: Indicators of change and insights into background rates

European Journal of Cancer Prevention

Volumn 17, Issue 6, 2008, Pages 525-534

  Teta, Mary Jane ^a   Mink, Pamela J ^a,b   Lau, Edmund ^a   Sceurman, Bonnielin K ^a   Foster, Edward D ^a  

^a EXPONENT INC   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Asbestos; Epidemiology; Incidence; Mesothelioma; National Cancer Institute's Surveillance Epidemiology and end results program; Trends

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER REGISTRY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; OCCUPATIONAL EXPOSURE; PERITONEUM MESOTHELIOMA; PLEURA MESOTHELIOMA; PRIORITY JOURNAL;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ASBESTOS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PERITONEAL NEOPLASMS; PLEURAL NEOPLASMS; SEX CHARACTERISTICS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 56149119116     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3282f0c0a2     Document Type: Article

References (44)

1. Archer VE, Rom WN (1983). Trends in mortality of diffuse malignant mesothelioma of the pleura. Letter to the editor. The Lancet 2:112-113.
2. Bianchi C, Giarelli L, Grandi G (1997). Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev 6:162-166.
3. Blot WJ, Stone BJ, Fraumeni JF, Morris LE (1979). Cancer mortality in D.S. counties with shipyard industries during World War II. Environ Res 18: 281-290.
4. Cancer Statistics Working Group (2006). United States cancer statistics: 2003 incidence and mortality. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute.
5. Census Bureau (2006). Intercensal Estimates of the United States Population by Age and Sex, 1990-2000: All months. Available from URL: http://www.census.gov/popest/archives/EST90INTERCENSAL/US-EST90INT-07/ US-EST90INT-07-2000.CSV. [Accessed 23 February, 2007].
6. Fisher KW (1998). Asbestos in shipbuilding: summaries of significant historical and illustrative documents pertaining to United States shipbuilding practices 1930's-1970's. Florham Park, NJ: Fisher Maritime Transportation Counselors Inc.
7. Fisher KW (2001 ). Asbestos: examining the shipyard's responsibility. Florham Park, NJ: Fisher Maritime Transportation Counselors Inc.
8. Fleischer WE, Viles FJ, Gade RL, Drinker P (1946). A health survey of pipe covering operations in constructing naval vessels. Am J Ind Hyg Toxicol 28:9-16.
9. Hankey BF, Ries LA, Edwards BK (1999). The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 8:1117-1121.
10. Hillerdal G (1999). Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med 56:505-513.
11. Huncharek M (2002). Non-asbestos related diffuse malignant mesothelioma. Tumori 88:1-9.
12. Ilgren EB, Wagner JC (1991). Background incidence of mesothelioma: animal and human evidence. Regul Toiticol Pharmacol 13:133-149.
13. Kanazawa N, Ioka A, Tsukuma H, Ajiki W, Oshima A (2006). Incidence and survival of mesothelioma in Osaka, Japan. Jpn J Clin Oncol 36:254-257.
14. La Vecchia C, Decarli A, Peto J, Levi F, Tomei F, Negri E (2000). An age, period and cohort analysis of pleural cancer mortality in Europe. Eur J Cancer Prev 9:179-184.
15. Lanphear BP, Buncher CR (1992). Latent period for malignant mesothelioma of occupational origin. J Occup Med 34:718-721.
16. Leigh J, Davidson P, Hendrie L, Berry D (2002). Malignant mesothelioma in Australia, 1945-2000. Am J Ind Med 41:188-201.
17. Light RW (2005). Disorders of the pleura, mediastrinum, diaphram, and chest wall. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 16th ed. Harrison's Online CD.
18. McDonald AD, McDonald JC (1980). Malignant mesothelioma in North America. Cancer 46:1650-1656.
19. McDonald JC (1985). Health implications of environmental exposure to asbestos. Environ Health Persp 62:319-328.
20. McDonald AD, McDonald JC (1985). Mesothelioma and asbestos fibre type. Br J Ind Med 42:567-568.
21. McDonald JC, McDonald A (1994). Mesothelioma: is there a background? In: Jaurand M, Bignon J, editors. The mesothelial cell and mesothelioma. New York: Marcel Dekker, Inc. pp. 37-45.
22. McElvenny DM, Darnton AJ, Price MJ, Hodgson JT (2005). Mesothelioma mortality in Great Britain from 1968 to 2001. Occup Med (Lond) 55:79-87.
23. Murayama T, Takahashi K, Natori Y, Kurumatani N (2006). Estimation of future mortality from pleural malignant mesothelioma in Japan based on an agecohort model. Am J Ind Med 49:1-7.
24. National Park Service (NPS). Tending the homefront: many roles of bay area women during World War II. National Park Service. Available at: http://www.cr.nps.gov/nr/travel/wwllbayarea/womenatwar.htm. [Accessed 2006]
25. Neuberger M, Vutuc C (2003). Three decades of pleural cancer and mesothelioma registration in Austria where asbestos cement was invented. Int Arch Occup Environ Health 76:161-166.
26. Nicholson WJ (1982). Occupational exposure to asbestos: population at risk and projected mortality 1980-2030. Am 1 Med 3:259-311.
27. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002). Cancer in live continents. Vol. VIII. Lyon: IARC Scientific Publication No. 155.
28. Peto J, Decarli A, La Vecchia C, Levi F, Negri E (1999). The European mesothelioma epidemic. Br J Cancer 79:666-672.
29. Polednak AP (2003). Geographic distribution of incident mesothelioma in Connecticut men, 1990-1999. Int J Cancer 107:509-510.
30. Price B (1997). Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 145:211-218.
31. Price B, Ware A (2004). Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003. Am J Epidemiol 159:107-112.
32. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. editors. SEER Cancer Statistics Review, 1975-2002. National Cancer Institute. Last updated 2005 based on November 2004 SEER data submission. Available at: http://seer.cancer.gov/csr/1975_2002/ [Accessed 2006].
33. Rosner B (2003). Fundamentals of biostatistics. 5th ed. Boston, MA: Duxbury Press. SAS Institute, V9.1. Cary, NC. 2000;688-689.
34. Rothman KJ, Boice JD (1979). Epidemiologie analysis with a programmable calculator. Washington DC: NIH; Publication, pp. 79-1649.
35. Rushworth DH (2005). The navy and asbestos thermal insulation. Nav Eng J 117:35-42.
36. Spirtas R, Beebe GW, Connelly RR, Wright WE, Peters JM, Sherwin RP, et al. (1986). Recent trends in mesothelioma incidence in the United States. Am J Ind Med 9:397-407.
37. Spirtas R, Heineman EF, Bernstein L, Beebe GW, Keehn RJ, Stark A, et al. (1994). Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med 542:804-811.
38. Surveillance, Epidemiology, and End Results (SEER) program, (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 9 Regs Public-Use, Nov 2004 Sub (1973-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission. 2005a
39. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 13 Regs Public-Use, Nov 2004 Sub for Expanded Races (1992-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission. 2005b.
40. Teta MJ, Lau E, Sceurman BK, Wagner ME (2007). Therapeutic radiation for lymphoma: risk of malignant mesothelioma. Cancer 109:1432-1438.
41. Ulvestad B, Kjaerheim K, Moller B, Andersen A (2003). Incidence trends of mesothelioma in Noway, 1965-1999. Int J Cancer 107:94-98.
42. Walker AM, Loughlin JE, Friedlander ER, Rothman KJ, Dreyer NA (1983). Projections of asbestos-related disease 1980-2009. J Occup Med 25: 409-425.
43. Weill H, Hughes JM, Churg AM (2004). Changing trends in US mesothelioma incidence. Occup Environ Med 61:438-441.
44. Xu Z, Armstrong BK, Blundson BJ, Rogers JM, Musk AW, Shilkin KB (1985). Trends in mortality from malignant mesothelioma of the pleura, and production and use of asbestos in Australia. Med J Aust 143:185-187.